Central masked adjudication of stroke diagnosis at trial entry offered no advantage over diagnosis by local clinicians: Secondary analysis and simulation
Open Access
- 1 December 2018
- journal article
- review article
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 12, 176-181
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council
- National Institute for Health Research
This publication has 20 references indexed in Scilit:
- The impact of covariate misclassification using generalized linear regression under covariate–adaptive randomizationStatistical Methods in Medical Research, 2015
- Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trialThe Lancet, 2015
- Statistical Analysis Plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) TrialInternational Journal of Stroke, 2014
- Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trialContemporary Clinical Trials, 2011
- Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTsClinical Trials, 2009
- Effects of the End Point Adjudication Process on the Results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)Stroke, 2009
- Do we need to adjudicate major clinical events?Clinical Trials, 2008
- Systematic adjudication of myocardial infarction end-points in an international clinical trialTrials, 2001
- Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT studyTrials, 2001
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993